ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by Ameriprise Financial Inc.

Ameriprise Financial Inc. lowered its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 6.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 585,218 shares of the medical instruments supplier’s stock after selling 41,911 shares during the period. Ameriprise Financial Inc. owned about 2.39% of ICU Medical worth $90,804,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of ICUI. Barclays PLC grew its stake in ICU Medical by 15.6% during the 3rd quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier’s stock valued at $10,790,000 after acquiring an additional 8,010 shares in the last quarter. Franklin Resources Inc. lifted its stake in ICU Medical by 99.3% during the 3rd quarter. Franklin Resources Inc. now owns 11,708 shares of the medical instruments supplier’s stock worth $2,111,000 after acquiring an additional 5,834 shares in the last quarter. Principal Financial Group Inc. boosted its stake in shares of ICU Medical by 24.6% in the third quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock valued at $23,130,000 after purchasing an additional 25,031 shares during the period. Diversified Trust Co grew its stake in shares of ICU Medical by 32.3% in the fourth quarter. Diversified Trust Co now owns 3,301 shares of the medical instruments supplier’s stock worth $512,000 after acquiring an additional 805 shares in the last quarter. Finally, Inspire Investing LLC grew its stake in ICU Medical by 13.2% during the 4th quarter. Inspire Investing LLC now owns 2,601 shares of the medical instruments supplier’s stock worth $404,000 after purchasing an additional 303 shares in the last quarter. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

ICU Medical Price Performance

Shares of NASDAQ:ICUI opened at $142.65 on Friday. ICU Medical, Inc. has a 52 week low of $100.69 and a 52 week high of $196.26. The company has a 50-day moving average price of $140.72 and a 200 day moving average price of $155.57. The company has a market cap of $3.51 billion, a P/E ratio of -31.22 and a beta of 0.87. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75.

Wall Street Analysts Forecast Growth

ICUI has been the subject of several analyst reports. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a report on Tuesday, April 8th. Raymond James set a $97.00 target price on shares of ICU Medical in a report on Wednesday, March 12th. KeyCorp reduced their price objective on ICU Medical from $209.00 to $191.00 and set an “overweight” rating for the company in a research note on Monday, April 21st. Finally, StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research note on Friday, May 2nd. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $162.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.